Third-generation cephalosporins like cefotaxime and ceftriaxone are often used in the ICU to treat gram-negative infections resistant to first and second-generation antibiotics. Fourth-generation cefepime provides extended coverage against Pseudomonas aeruginosa and other gram-negative bacteria. Due to rising antibiotic resistance, beta-lactam/beta-lactamase inhibitor combinations like cefoperazone/sulbactam are frequently used, as sulbactam prevents hydrolysis by beta-lactamases. Cefoperazone/sulbactam in a 2:1 ratio is effective against multidrug-resistant bacteria and provides better penetration at higher